Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 6NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 4Lymphoid 3Thoracic 1Sarcoma 1Other hematologic neoplasm 1CNS 1

Conditions

Sarcoma 108Central Nervous System Neoplasms 42Osteosarcoma 38Gliosarcoma 34Glioblastoma 34Rhabdomyosarcoma 27Lymphoma 22Fibrosarcoma 22Liposarcoma 21Leiomyosarcoma 20Neuroblastoma 19Hemangiosarcoma 19Astrocytoma 19Sarcoma, Synovial 18Neuroectodermal Tumors, Primitive, Peripheral 18Dendritic Cell Sarcoma, Interdigitating 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Neurofibrosarcoma 17Histiocytoma, Malignant Fibrous 17Brain Neoplasms 17Sarcoma, Kaposi 16Malignant mesenchymal tumor 16Burkitt Lymphoma 16Ovarian Neoplasms 15Recurrence 14Leukemia 14Sarcoma, Alveolar Soft Part 12Oligodendroglioma 12AIDS-related Kaposi sarcoma 12Hemangiopericytoma, Malignant 11

Interventions

Razoxane 1Methotrexate 1Ifosfamide 1Etoposide 1Doxorubicin 1Dexrazoxane 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Cardiotoxicity × Sarcoma × Clear all
NCT00003937 2014-08-05

Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma

Children's Oncology Group

Phase 3 Completed
253 enrolled
Sarcoma

Sarcoma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡